打击耐药性肺炎:当前的治疗方案和未来的方向
Robiul Islam1,2, Shyamal C Das2, Daniel Pletzer1
1Department of Microbiology and Immunology, Faculty of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.
The Journal of antimicrobial chemotherapy
|February 24, 2026
概括
耐多药的Klebsiella pneumoniae会导致严重的肺炎. 本综述考察了组合疗法和吸入抗生素,强调了有效治疗策略的挑战和未来研究方向.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 克莱布西拉肺炎是医院获得的肺炎的重要原因之一.
- 在K. pneumoniae中不断升级的多药耐药性构成了全球严重的健康威胁.
- 了解耐药机制对于开发有效的治疗方法至关重要.
研究的目的:
- 审查目前针对多药耐药的K. pneumoniae肺部感染的治疗策略.
- 评估抗生素组合疗法的疗效和局限性.
- 探索吸入抗生素作为一个有前途的治疗方法.
主要方法:
- 审查当前治疗策略的进展.
- 对抗生素联合治疗 (双重和三重药物治疗方案) 的证据分析.
- 讨论耐药性决定因素和机制 (例如,blaKPC,blaNDM,mcr基因,毛孔突变,排泄,酶降解).
主要成果:
- 组合疗法 (例如,胆固醇素/美罗烯,聚素B/美罗烯/里芬) 显示出潜力,但存在局限性.
- 抵抗机制的区域差异使治疗复杂化.
- 吸入抗生素的输送提供了向的肺药物度和降低了全身毒性.
结论:
- 与单一治疗相比,抗生素组合治疗的疗效需要进一步研究.
- 吸入抗生素,特别是干粉吸入器,是一种有前途的策略.
- 诸如配方稳定性,监管问题和有限的临床试验等障碍需要解决,以便在未来研究中对抗抗性K. pneumoniae肺部感染.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
15.3K
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
5.5K
相关概念视频
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
509
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
509
01:28Pulmonary Tuberculosis V
680
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
680
01:28Pneumonia IV: Management
868
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
868
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
52
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
52
01:27Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K
01:30Development of Antibiotic Resistance
1.7K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K